The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide
- 1 February 1982
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 10 (1) , 1-14
- https://doi.org/10.1007/bf01059180
Abstract
Disopyramide exhibits saturable binding to plasma proteins in the therapeutic plasma concentration range. Because of this property, controversy exists in the literature regarding the pharmacokinetic properties of the drug. The purposes of this study were to reassess the pharmacokinetic properties of disopyramide in humans, taking into consideration both total and unbound concentrations and to use disopyramide as a model compound to study the effect of drug binding on the renal clearance of both total and unbound drug. A single intravenous dose of disopyramide (1.5 mg/kg) was administered to eight normal volunteers. Blood and urine samples were collected for 36h. Total concentrations of disopyramide in plasma and urine were determined by high pressure liquid chromatography. Binding of disopyramide to plasma proteins was determined by equilibrium dialysis. In all subjects, the binding of disopyramide to plasma proteins was saturable, but there were considerable differences in binding between subjects. The volume of distribution, total body clearance, and renal clearances of both total and unbound drug were calculated. Because only the total body clearance and renal clearance of unbound compound are not dependent upon unbound fraction (α), these are the only parameters which can be reported without qualification as to the concentration. The mean ± SD total body clearance of unbound drug in the eight subjects was 5.40± 2.80 ml/min/kg. About 50% of this was due to renal elimination. A statistically significant negative correlation of the renal clearance of total disopyramide with time was observed in seven of eight subjects, whereas a significant correlation between the renal clearance of unbound disopyramide and time was observed in only one subject. This suggests that the renal clearance of unbound disopyramide is independent of α, while the renal clearance of total disopyramide is dependent upon α.Keywords
This publication has 20 references indexed in Scilit:
- Effect of saturable binding on the pharmacokinetics of drugs: a simulationJournal of Pharmacy and Pharmacology, 1980
- Effect of Plasma Protein Binding on Renal Clearance of DrugsJournal of Pharmaceutical Sciences, 1980
- The renal clearance of disopyramide after bolus intravenous injectionBiopharmaceutics & Drug Disposition, 1979
- Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.Published by Wiley ,1979
- Role of concentration-dependent plasma protein binding in disopyramide dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Assay of disopyramide in plasma by high-ressure liquid chromatographyJournal of Chromatography A, 1978
- PHARMACOKINETICS AND STEADY-STATE MYOCARDIAL UPTAKE OF DISOPYRAMIDE IN DOG1978
- Pharmacokinetics of the antiarrhythmic disopyramide in healthy humansJournal of Pharmacokinetics and Biopharmaceutics, 1976
- The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.1976
- The pharmacokinetics of Norpace.1975